论文部分内容阅读
目的:对中西药不合理配伍的分析与影响进行了研究。方法:研究中选择了本院2015年9月到2016年1月的700张中西药处方进行了研究,通过查询文献、搜集整理,对处方结果进行了分析。结果:通过对注射剂不合理配伍处方的研究分析可以发现,在复方丹参注射液以及头孢曲松钠不合理配伍处方中,会使患者在接受治疗中产生较多的黑色颗粒,灯盏花素粉针以及孢拉定注射液不合理配伍处方中,会使患者出现浑浊,颜色呈黄绿色、黄茶色变化的不良结果。同时,对中西配伍不合理处方进行了分析,理化性质改变在不合理处方中所占比例为25.00%,拮抗作用在不合理处方中所占比例为22.00%,加重毒副作用的在不合理处方中所占的比例相对较多,其比例为43.00%。数据研究中无明显差异,具有统计学意义(P<0.05)。结论:中西药配伍不合理问题,需要得到医务工作者的重视,通过对中西医处方的合理配合,提高配伍就用药的安全性。
Objective: To study the analysis and influence of irrational compatibility of Chinese and Western medicine. Methods: In this study, we selected 700 prescriptions of traditional Chinese and western medicine from September 2015 to January 2016 in our hospital. The results of the prescriptions were analyzed by consulting the literature and collecting them. Results: Through the unreasonable injection prescription study and analysis can be found in the compound Danshen injection and ceftriaxone unreasonable prescription, will make patients in the treatment of more black particles, Breviscapine powder As well as unreasonable compatibility Spradin injection prescription, will make patients appear cloudy, yellow-green color, yellow brown color of the bad results. At the same time, the unreasonable prescriptions of Chinese and Western compatibility were analyzed. The changes of physical and chemical properties accounted for 25.00% of the unreasonable prescriptions, and the antagonistic effects accounted for 22.00% of the unreasonable prescriptions. The proportion is relatively large, the proportion is 43.00%. There was no significant difference in data research, with statistical significance (P <0.05). Conclusion: The irrational compatibility of traditional Chinese and western medicines needs the attention of medical workers. By rationalizing the prescriptions of traditional Chinese medicine and western medicine, the safety of compatibility is improved.